The evidence is balanced enough to avoid a defensive call, but not aligned enough for aggressive positioning.
58
technical evidence
out of 100
out of 100
Week Ending: 28 August 2026
United States US Healthcare Industry
Health Information Services
For the week ending 28 August 2026, Health Information Services declined 1.19% with 16 advancing, 23 declining, and 1 unchanged constituents. The index is equal weighted and the constituent tape shows uncapped security returns.
Current architecture
Upward Expansion
The activity fan is positively ordered above a rising Trend Line with price accepted above it.
58
technical evidence
Index608.38
1 week-1.19%
Breadth40%
Members41
Country
🇺🇸 United States · US
Sector
Healthcare
Universe
NASDAQ, NYSE
Price basis
Adjusted weekly close
Trend architecture
Index, activity fan and structural anchors
Rolling 156-week evidence. Trend Signal points mark weeks when price, trend and the activity fan confirmed together.
Index Value
Trend Line
Fair Value
Activity Lines
Constructive architecture
Transitional architecture
Defensive architecture
Current architecture
Upward Expansion
5 completed weeks in this state
Trend acceptance
14.6%
Index versus Trend Line
Persistence
50%
Negative regime, shorter trend repairing
Participation
40%
16 advancing, 23 declining
Investor positioning lens
Is the evidence ready for capital?
A rules-based technical classification using trend, breadth, persistence, relative strength and path quality.
Evidence balance
Wait
Five-pillar map
Trend
74
Breadth
46
Persistence
51
Relative
51
Risk quality
69
What supports the view
- The index remains above a constructive Trend gate.
What restrains conviction
- Breadth remains too narrow or inconsistent for a high-conviction position.
- Constituent persistence remains divided or predominantly negative.
- The group is not yet delivering dependable relative outperformance.
- Stage 4 declining constituents exceed Stage 2 advancing constituents by 14 percentage points.
This is a weekly research classification, not personal investment advice. Sentiment is reported as an independent confirmation layer and does not alter the technical score.
Trend state and durability
Architecture, persistence and constituent regimes
The index path is tested against the underlying security-level trend evidence.
The activity fan is positively ordered above a rising Trend Line with price accepted above it.
State age5 weeks
Trend gateUp
Fan width8.85%
Fast versus slow change1.30 pts
Above 67%
Below 0%
Six completed weeks of price acceptance relative to the full Activity Line fan.
Index persistence
50% agreement
Negative regime, shorter trend repairing
The long trend remains negative, but shorter-horizon repair is now visible.
13-week
13.3%
26-week
19.7%
39-week
-6.6%
52-week
-14.2%
Constituent trend persistence
98% coverage
Is the index move broadly durable?
33%positive
Coherent positive31%
Coherent negative15%
Average horizon agreement77%
Positive horizon share53%
Weakening positives1
Repairing negatives14
39 constituents measured as of 21 Aug 2026. Median trend age is 31 weeks.
Custom stage map
88% coverage
Where constituents sit in the cycle
43%Stage 1
Stage 1 · Basing43%15 securities
Stage 2 · Advancing20%7 securities
Stage 3 · Distribution3%1 securities
Stage 4 · Declining34%12 securities
Re-acceleration watch0
Transition watch6
Relative strength leaders34%
Fair Value repairs13
Measured as of 21 Aug 2026. Stages summarize price, Activity Line architecture, Fair Value position and relative evidence.
Architecture breadth
76/100 mean confidence
How market energy is distributed
Architecture breadth shows the distribution of expanding, rotating, balancing and contracting securities. It is diagnostic context and is not added as a second vote in the positioning score.
Capital rotation
Performance relative to Healthcare
Relative index
13-week relative trend
Starting level
A rising relative line means this group is compounding faster than Healthcare. A falling line means capital has done better in the parent benchmark.
Relative index77.6
13-week trend75.3
4-week trend change3.37%
Weekly peer rank6 of 11
1 week
0.2 pts
relative
4 weeks
2.6 pts
relative
13 weeks
9.4 pts
relative
26 weeks
16.0 pts
relative
52 weeks
-24.5 pts
relative
Market internals
Participation, dispersion and path risk
Equal-weight index evidence with constituent-level breadth and dispersion.
Breadth
Narrow
Participation quality
40%
advanced
- Advancing
- 16
- Declining
- 23
- Unchanged
- 1
Risk and persistence
52-week lens
Path quality
Annualised weekly volatility29.4%
Drawdown from 52-week high-17.2%
Positive weeks, last 1346%
Current directional run1 week
Turnover versus 13-week norm65%
Breadth impulse-12.9 pts
Cross-section
40 measured
Return distribution
Q1 -4.8%
Median -0.8%
Q3 2.5%
Average winner4.2%
Average loser-5.7%
Dispersion8.2 pts
Top-five upside share60%
Top-five capital share65%
Capital data coverage100%
Dispersion describes how far constituent outcomes are spreading apart. Capital concentration is contextual only; the index itself is equal weighted.
Momentum cycle
30-week persistence
Positive readings show expansion. Negative readings show contraction.
Breadth cycle
Net participation
Advancers less decliners as a percentage of measured constituents.
News and narrative
Does company news confirm the market tape?
57out of 100
More positive than negative
Positive company scores outnumber negative ones, but the overall score remains close to 50.
Evidence quality
50/100 confidence
Coverage before conviction
Qualified companies615% of measured constituents
Articles447100% direct company evidence
Publishers113Independent sources represented
Latest evidence29 AugFreshness is weighted in the score
Constructive 50%Balanced 33%Cautious 17%
Price confirms news2
Price disagrees2
Negative news absorbed1
Positive but stretched0
Constructive edge
Strongest qualified tone
VEEV67/100 confidence · 61 direct
70
Veeva (VEEV) Grew Subscription Revenue 16% as GAAP Operating Income Increased 40%. Is the M…
HQY67/100 confidence · 77 direct 62HealthEquity (NASDAQ:HQY) Trading 4.4% Higher Following Strong Earnings
DOCS36/100 confidence · 92 direct 58Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Kn…
HTFL43/100 confidence · 82 direct 56Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT An…
TEM43/100 confidence · 86 direct 55Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just…
Narrative risk
Weakest qualified tone
TDOC42/100 confidence · 49 direct
40
Teladoc Health (TDOC) Cuts Revenue Outlook, Is Integrated Care Enough To Support Fair Value?
TEM43/100 confidence · 86 direct 55Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just…
HTFL43/100 confidence · 82 direct 56Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT An…
DOCS36/100 confidence · 92 direct 58Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Kn…
HQY67/100 confidence · 77 direct 62HealthEquity (NASDAQ:HQY) Trading 4.4% Higher Following Strong Earnings
Only fresh, quality-controlled company evidence is included. Industry and sector context is down-weighted and cannot create a directional group conclusion on its own.
Leadership tape
Leaders, laggards and contribution shape
Latest completed week, ranked on uncapped constituent returns.
Constituent ledger
Industry constituents
All 40 measured constituents, ranked by latest weekly return.
Rank
Ticker
Company
Exchange
Market cap
Close
Index contribution
Return
The index uses capped equal-weight weekly constituent returns. The ledger shows uncapped security returns so outliers remain visible for research.